UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter to the editor to 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2380566

2024

Volltextzugriff (PDF)

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2380568

2024

Volltextzugriff (PDF)

Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2355683

2024

Volltextzugriff (PDF)

Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2396710

2024

Volltextzugriff (PDF)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301632-2301632

2024

Volltextzugriff (PDF)

In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (18), p.9731-9752

2024

Volltextzugriff (PDF)

Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison

International journal of pharmaceutics, 2024-12, Vol.666, p.124842, Article 124842

2024

Volltextzugriff (PDF)

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus

Vaccine, 2024-12, Vol.42 (26), p.126384, Article 126384

2024

Volltextzugriff (PDF)

Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes

Vaccine, 2024-12, Vol.42 (26), p.126454, Article 126454

2024

Volltextzugriff (PDF)

Designing a novel chimeric multi-epitope vaccine subunit against Staphylococcus argenteus through artificial intelligence approach integrating pan-genome analysis, in vitro identification, and immunogenicity profiling

Journal of biomolecular structure & dynamics, 2024-12, Vol.42 (19), p.10401-10416

2024

Volltextzugriff (PDF)

Enhanced immune response with baculovirus-expressed BoHV-1 glycoprotein D in vaccine development

The veterinary journal (1997), 2024-12, Vol.308, p.106228, Article 106228

2024

Volltextzugriff (PDF)

Identification of immunogenic antigens and evaluation of vaccine candidates against Clostridium perfringens

Poultry science, 2024-12, Vol.103 (12), p.104436, Article 104436

2024

Volltextzugriff (PDF)

Evaluation of protective efficacy of recombinant Toxoplasma gondii DDX39 protein vaccine against acute and chronic T. gondii infection in mice

Acta tropica, 2024-12, Vol.260, p.107442, Article 107442

2024

Volltextzugriff (PDF)

Designing a multi-epitope subunit vaccine against Orf virus using molecular docking and molecular dynamics

Virulence, 2024-12, Vol.15 (1), p.2398171

2024

Volltextzugriff (PDF)

ASFV subunit vaccines: Strategies and prospects for future development

Microbial pathogenesis, 2024-12, Vol.197, p.107063, Article 107063

2024

Volltextzugriff (PDF)

Immunogenicity analysis based on VP1 and VP2 proteins of bovine enterovirus

Virology (New York, N.Y.), 2024-12, Vol.600, p.110260, Article 110260

2024

Volltextzugriff (PDF)

Vaccination with OprB porin, and its epitopes offers protection against A. baumannii infections in mice

International immunopharmacology, 2024-11, Vol.141, p.112972, Article 112972

2024

Volltextzugriff (PDF)

Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists

European journal of medicinal chemistry, 2024-11, Vol.278, p.116792, Article 116792

2024

Volltextzugriff (PDF)

Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice

Vaccine, 2024-11, Vol.42 (25), p.126213, Article 126213

2024

Volltextzugriff (PDF)

Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2

European journal of pharmaceutics and biopharmaceutics, 2024-11, Vol.204, p.114528, Article 114528

2024

Volltextzugriff (PDF)

Proanthocyanidins-based adjuvant for enhanced immune responses of SARS-CoV-2 subunit vaccine

Journal of drug delivery science and technology, 2024-11, Vol.101, p.106185, Article 106185

2024

Volltextzugriff (PDF)

A novel oral vaccine delivery system for enhancing stability and immune protection: bacterium-like particle with functional coating

Frontiers in microbiology, 2024-10, Vol.15

2024

Volltextzugriff (PDF)

Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models

Scientific reports, 2024-10, Vol.14 (1), p.25528-14, Article 25528

2024

Volltextzugriff (PDF)

Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice

Vaccine, 2024-10, Vol.42 (24), p.126084, Article 126084

2024

Volltextzugriff (PDF)

Vaccination with a Lawsonia intracellularis subunit water in oil emulsion vaccine mitigated some disease parameters but failed to affect shedding

Vaccine, 2024-10, Vol.42 (24), p.126254, Article 126254

2024

Volltextzugriff (PDF)

1 – 25 von 6.657

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.280)
Mit Volltextzugriff
(5.816)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.856)
Life Sciences & Biomedicine
(5.406)
Animals
(3.993)
Humans
(3.164)
Immunology
(3.089)
Vaccines, Subunit - Immunology
(2.669)
Vaccines
(2.549)
Mice
(2.281)
Female
(2.030)
Microbiology
(1.430)
Proteins
(1.328)
Antigens
(1.319)
Biological And Medical Sciences
(1.291)
Medicine, Research & Experimental
(1.274)
Research & Experimental Medicine
(1.274)
Immunization
(1.201)
Vaccines, Subunit - Administration & Dosage
(1.183)
Vaccination
(1.126)
Subunit Vaccine
(1.053)
Mice, Inbred Balb C
(1.051)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.782)
Ingenta.com
(3.873)
Free E-Journal (出版社公開部分のみ）
(2.993)
Elsevier ScienceDirect Journals Complete
(2.100)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.951)
RCN full-text journals@Ovid
(1.662)
IngentaConnect Journals
(1.621)
NUS Single-Journal Subscriptions
(942)
Wiley-Blackwell Journals
(615)
SpringerLink_现刊
(571)
Taylor & Francis Journals
(503)
Taylor & Francis
(479)
Taylor & Francis Online
(442)
Wiley Online Library Full Collection 2018
(380)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(368)
Nature_系列刊
(282)
Oxford journals
(199)
JSTOR
(184)
Nexis Uni
(166)
Oxford Journals 2020 Medicine
(155)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(953)
Plos One
(171)
Expert Review Of Vaccines
(158)
Frontiers In Immunology
(156)
Human Vaccines & Immunotherapeutics
(135)
Vaccines
(124)
The Journal Of Immunology
(115)
Infection And Immunity
(114)
The journal Of Immunology/the journal Of Immunology
(107)
Scientific Reports
(72)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Letter to the editor to 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'

Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study

Enhancement of HPV therapeutic peptide-based vaccine efficacy through combination therapies and improved delivery strategies: A review

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis

Evaluation of PLGA, lipid-PLGA hybrid nanoparticles, and cationic pH-sensitive liposomes as tuberculosis vaccine delivery systems in a Mycobacterium tuberculosis challenge mouse model – A comparison

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus

Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes

Designing a novel chimeric multi-epitope vaccine subunit against Staphylococcus argenteus through artificial intelligence approach integrating pan-genome analysis, in vitro identification, and immunogenicity profiling

Enhanced immune response with baculovirus-expressed BoHV-1 glycoprotein D in vaccine development

Identification of immunogenic antigens and evaluation of vaccine candidates against Clostridium perfringens

Evaluation of protective efficacy of recombinant Toxoplasma gondii DDX39 protein vaccine against acute and chronic T. gondii infection in mice

Designing a multi-epitope subunit vaccine against Orf virus using molecular docking and molecular dynamics

ASFV subunit vaccines: Strategies and prospects for future development

Immunogenicity analysis based on VP1 and VP2 proteins of bovine enterovirus

Vaccination with OprB porin, and its epitopes offers protection against A. baumannii infections in mice

Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists

Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice

Fluoroamphiphiles for enhancing immune response of subunit vaccine against SARS-CoV-2

Proanthocyanidins-based adjuvant for enhanced immune responses of SARS-CoV-2 subunit vaccine

A novel oral vaccine delivery system for enhancing stability and immune protection: bacterium-like particle with functional coating

Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models

Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice

Vaccination with a Lawsonia intracellularis subunit water in oil emulsion vaccine mitigated some disease parameters but failed to affect shedding

Suchergebnisse filtern